ARCHIVED — Vol. 149, No. 43 — October 24, 2015

Warning This Web page has been archived on the Web.

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

GOVERNMENT NOTICES

BANK OF CANADA

AMENDMENT TO THE BANK OF CANADA SUPPLEMENTARY PENSION ARRANGEMENT (BY-LAW 18)

CERTIFICATE

I, Jeremy Farr, General Counsel and Corporate Secretary of the Bank of Canada, hereby certify that, pursuant to subsection 15(2) of the Bank of Canada Act, the following amendment to By-law 18 of the Bank of Canada has been duly approved by the Board of Directors of the Bank on 24 September 2015, and that it has not been amended or rescinded since that date.

Ottawa, October 5, 2015

JEREMY FARR
General Counsel and Corporate Secretary

BY-LAW 18 — AMENDMENT TO THE BANK OF CANADA SUPPLEMENTARY PENSION ARRANGEMENT (THE “ARRANGEMENT”)

WHEREAS pursuant to subsection 15(2) of the Bank of Canada Act, the Board of Directors of the Bank has passed By-law 18, to establish a supplementary pension arrangement for the benefit of its eligible employees and their dependants;

AND WHEREAS the Bank has the authority to amend its By-laws;

IT IS HEREBY RESOLVED that the Bank of Canada Supplementary Pension Arrangement, By-law 18, is hereby amended, with effect from the date of publication in the Canada Gazette, pursuant to subsection 35(2) of the Act, by:

Deleting subsection 10.2 and replacing it by the following:

“10.2 MARRIAGE BREAKDOWN

Notwithstanding any other provision of this Arrangement, where all or a portion of a participant’s entitlement under the Pension Plan has been assigned to his or her spouse or former spouse in accordance with paragraph 11.2.2 of the Pension Plan, the participant’s entitlement under the Arrangement shall be determined as if no such assignment had occurred in the Pension Plan. For greater clarity, benefits accrued under the Arrangement are not subject to assignment on marriage breakdown regardless of the treatment of benefits accrued under the Pension Plan.”

[43-1-o]

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Order 2015-87-11-02 Amending the Non-domestic Substances List

Whereas, pursuant to subsection 87(5) of the Canadian Environmental Protection Act, 1999 (see footnote a), the Minister of the Environment has added the substances referred to in the annexed Order to the Domestic Substances List (see footnote b);

Therefore, the Minister of the Environment, pursuant to subsection 87(5) of the Canadian Environmental Protection Act, 1999 (see footnote c), makes the annexed Order 2015-87-11-02 Amending the Non-domestic Substances List.

Gatineau, October 9, 2015

LEONA AGLUKKAQ
Minister of the Environment

ORDER 2015-87-11-02 AMENDING THE NON-DOMESTIC SUBSTANCES LIST

AMENDMENTS

1. Part I of the Non-Domestic Substances List (see footnote 1) is amended by deleting the following:

  • 189378-12-9
  • 1043888-25-0

2. Part II of the List is amended by deleting the following:

18585-0 N Alkanoic acid, mixed polyesters with ethylalkanoic acid, alkanoic acid, pentaerythritol and alkanoic acid
  Acide alcanoïque, mélanges de tétraesters avec un acide éthylalcanoïque, un autre acide alcanoïque, le 2,2-bis(hydroxyméthyl)propane-1,3-diol et un troisième acide alcanoïque

COMING INTO FORCE

3. This Order comes into force on the day on which Order 2015-87-11-01 Amending the Domestic Substances List comes into force.

[43-1-o]

DEPARTMENT OF HEALTH

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Decisions, undertakings and orders on claims for exemption

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer hereby gives notice of the decisions of the screening officer respecting each claim for exemption and the relevant material safety data sheet (MSDS) and (where applicable) the label listed below.

In accordance with section 20 of the Hazardous Materials Information Review Act, a claimant or any affected party, as defined, may appeal a decision or order of a screening officer. An affected party may also appeal an undertaking in respect of which a notice has been published in the Canada Gazette. To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered, along with the fee prescribed by section 12 of the Hazardous Materials Information Review Regulations, within 45 days of the publication of this notice in the Canada Gazette, Part I, to the Chief Appeals Officer at the following address: Workplace Hazardous Materials Bureau, 269 Laurier Avenue West, 4th Floor, Ottawa, Ontario K1A 0K9.

ROSSLYNN MILLER-LEE
Chief Screening Officer

On February 11, 2015, the Hazardous Products Act (HPA) was amended, and the Controlled Products Regulations (CPR) and the Ingredient Disclosure List were repealed and replaced with the new Hazardous Products Regulations (HPR). The revised legislation (HPA/HPR) is referred to as WHMIS 2015 and the former legislation (HPA/CPR) is referred to as WHMIS 1988.

Transitional provisions allow compliance with either WHMIS 1988 or WHMIS 2015 for a specified period of time. All claims for exemption in this publication were filed and evaluated in accordance with the provisions of WHMIS 1988.

There were no written representations from affected parties with respect to any of the claims for exemption and related MSDSs or labels mentioned below.

Each of the claims for exemption listed in the table below was found to be valid except for those for Registry Numbers (RNs) 9016, 9036, 9051, 9141, 9274, 9275, 9276, 9277, 9278, 9299, 9306, 9307, 9318, 9335, 9342 and 9365, which were found to be partially valid, and RNs 9035, 9042, 9297, 9322, 9324 and 9345, which were found to be invalid. The screening officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations.

Claimant Product Identifier RN Date of Decision
3M Canada Company 3M™ Anisotropic Conductive Film 7376-30 8885 26/05/2015
Produits Environnementaux Greensolv Inc. G-Strip 255-8ADD 9002 16/03/2015
Produits Environnementaux Greensolv Inc. GREENSOLV 294WL 9016 16/03/2015
Chevron Oronite Company LLC LUBAD 1761 9032 01/05/2015
Calfrac Well Services Ltd. DWP-126 9033 07/04/2015
Dow Corning Corporation DOW CORNING® WG-9010 OPTICAL ADHESIVE 9034 07/04/2015
Win Chemicals Ltd. JK-50 9035 27/04/2015
Win Chemicals Ltd. LFQ 9036 14/04/2015
Win Manuco Ltd. eQi 9037 15/05/2015
Schlumberger Canada Limited EZEFLO F108 Surfactant 9042 29/04/2015
Nalco Canada ULC Flotron® M-300 9044 26/05/2015
GE Water & Process Technologies Canada SPEC-AID 8Q7501ULS 9045 03/03/2015
GE Water & Process Technologies Canada SPEC-AID 8Q5373ULS 9046 19/05/2015
Akzo Nobel Surface Chemistry LLC Redicote® AP-1 9051 03/03/2015
Afton Chemical Corporation POLARTECH AMIDE MA 550 DT 9053 27/05/2015
E.I. DuPont Canada Company Capstone® FS-35 9058 22/05/2015
Allnex Canada Inc., c/o Goodmans, LLP DESMOLUX® VPLS 2265 Radiation Curing Resins 9059 20/05/2015
Allnex Canada Inc., c/o Goodmans, LLP DESMOLUX® U 100 Radiation Curing Resins 9061 20/05/2015
Allnex Canada Inc., c/o Goodmans, LLP DESMOLUX® D 100 Radiation Curing Resins 9062 26/05/2015
Halliburton Energy Services Inc. FR-66 9068 02/04/2015
Halliburton Energy Services Inc. CL-23 Crosslinker 9069 01/05/2015
Trican Well Service Ltd. Mudwash 9071 22/04/2015
Trican Well Service Ltd. MWC-2 9072 22/04/2015
Weatherford PE 810 9090 26/05/2015
Weatherford HGA-70 9091 26/05/2015
Hach Company Amino Acid F Reagent Powder for Analyzers 9094 04/05/2015
Allnex Canada Inc., c/o Goodmans, LLP EBECRYL® 3701 Radiation Curing Resins 9100 20/05/2015
Xypex Chemical Corporation Xypex Concentrate 9123 08/05/2015
Xypex Chemical Corporation Xypex Modified 9124 08/05/2015
Xypex Chemical Corporation Xypex Patch’n Plug 9125 08/05/2015
Enthone, Inc. CUPROSTAR® AUX 9141 22/05/2015
Nalco Canada ULC NALFLOTE® 9837 9179 08/04/2015
The Lubrizol Corporation ANGLAMOL® 99 9188 06/11/2014
Baker Petrolite Corp. TOPGUARD™ 1222 CORROSION INHIBITOR 9198 26/05/2015
GE Water & Process Technologies Canada PROSWEET* OC2557 9232 07/05/2015
Champion Technologies Ltd. Surfatron DN-158 9268 30/03/2015
The Lubrizol Corporation LUBRIZOL® IG93MA 9272 14/04/2015
Afton Chemical Corporation HiTEC® 3418M Performance Additive 9274 13/03/2015
SaskPower BDPS ICCS DC-103 Lean, In-Service Amine Absorbent: aka “Lean C02 Amine” 9275 21/04/2015
SaskPower BDPS ICCS DS Acid-Treated, Lean, In-Service Amine Absorbent: aka “Lean S02 Amine” 9276 21/04/2015
SaskPower BDPS ICCS DC-103 Rich, In-Service Amine Absorbent: aka “Rich C02 Amine” 9277 21/04/2015
SaskPower BDPS ICCS DS Acid-Treated, Rich, In-Service Amine Absorbent: aka “Rich S02 Amine” 9278 21/04/2015
DuPont Electronic and Communication Technologies - MCM 7105 9281 02/03/2015
DuPont Electronic and Communication Technologies - MCM 5642 9282 01/04/2015
E.I. DuPont Canada Company Endimal™PT 9283 13/03/2015
E.I. DuPont Canada Company Endimal® 500 9284 13/03/2015
CESI Chemical FE-7 9287 16/04/2015
CESI Chemical FE-8 9288 16/04/2015
Nalco Canada ULC Assure HI-203 9290 03/03/2015
IPAC Chemicals Ltd. Envirobind DCT 9291 03/03/2015
Trican Well Service Ltd. FC-2 9292 12/03/2015
Halliburton Energy Services Inc. CL-40™ CROSSLINKER 9294 03/03/2015
Rohm and Haas Canada LP ROMAX™ Activator 1001 9295 20/04/2015
Nalco Canada ULC Flow Plus VR-1100 9296 03/03/2015
Rohm and Haas Canada LP Paraloid EXL-2690 Powder 9297 23/03/2015
Nalco Canada ULC 3D TRASAR® 3DT237 9298 03/03/2015
MeadWestvaco Corp. Specialty Chemicals Div. EnvaWet™ SCTO 9299 09/02/2015
Chevron Oronite Company LLC OGA 293HF 9300 23/03/2015
Air Products and Chemicals, Inc. ANCAMINE®2014AS Curing Agent 9301 03/03/2015
Air Products and Chemicals, Inc. SURFYNOL®TG SURFACTANT 9302 03/03/2015
Hydro Technologies (Canada) Inc. HY BRITE® RT-3000 9303 03/03/2015
Chevron Oronite Company LLC MAR 730P 9304 12/03/2015
DuPont Electronic and Communication Technologies - MCM 7292 9305 07/04/2015
Afton Chemical Corporation NEMO 1126T 9306 17/04/2015
Afton Chemical Corporation HiTEC® 6606T Fuel Additive 9307 17/04/2015
Evonik Corporation Protectosil® 300 S 9308 03/03/2015
Guardian Chemicals Inc. PRESSGUARD HP 9310 23/03/2015
Chevron Oronite Company LLC OLOA 49828 9311 03/03/2015
Air Products and Chemicals Inc. ANCAMINE®2264 Curing Agent 9312 06/02/2015
Canadian Energy Services EnerHIB 9313 16/04/2015
PCT Global PTY LTD. ENDUROSHIELD GLASS PROFESSIONAL (US) 9314 05/03/2015
PCT Global PTY LTD. ENDUROSHIELD TILES & GROUT PROFESSIONAL (US) 9315 05/03/2015
PCT Global PTY LTD. ENDUROSHIELD AUTO GLASS PROFESSIONAL (US) 9316 05/03/2015
PCT Global PTY LTD. ENDUROSHIELD STAINLESS STEEL PROFESSIONAL (US) 9317 05/03/2015
Afton Chemical Corporation LUBAD 1797 9318 10/03/2015
STIMWRX Energy Services Ltd. STIMWRX-EH3 9319 31/03/2015
Baker Petrolite Corp. PAO2360 PARAFFIN CONTROL 9320 24/02/2015
Air Products and Chemicals, Inc. ANQUAMINE® 401 Curing Agent 9321 12/02/2015
Rohm and Haas Canada LP Paraloid® KM-X100 PRO Impact Modifier 9322 23/03/2015
Dow Chemical Canada ULC SELEXOL™ Solvent 9323 16/03/2015
Evonik Corporation Dynasylan® HYDROSIL 2776 9324 03/03/2015
Nalco Canada ULC NALSIZE® 7548 9325 08/04/2015
Evonik Corporation Protectosil® 300 C 9326 09/03/2015
Home Hardware Stores Limited Paint and Home Products Division Activox Cleaner 9327 15/04/2015
Home Hardware Stores Limited Paint and Home Products Division Activox Activator 9328 15/04/2015
E.I. DuPont Canada Company DuPont™ Cyrel® Cylosol Component A 9330 27/04/2015
E.I. DuPont Canada Company DuPont™ Cyrel® Cylosol Component B 9331 27/04/2015
Cambrian Solutions Inc. Cambrex XAS 9332 10/03/2015
Diversity Technologies Corp. CHEM CLEAN GREEN 9333 27/04/2015
Momentive Performance Materials Niax* Silicone L-6705 9334 09/03/2015
Momentive Performance Materials Y-16251 9335 24/04/2015
Secure Energy Services Inc. SECURE CI-810 9336 19/05/2015
RoMix, Inc. Back-Set Molecular Cement Dissolver 9337 24/03/2015
Trican Well Service Ltd. SS-7 9338 01/04/2015
Engenium Chemicals Corporation IH-FR-8 9339 04/03/2015
Engenium Chemicals Corporation IH-FM-8 9340 04/03/2015
Afton Chemical Corporation HiTEC® 2317 Performance Additive 9342 14/04/2015
BWA Water Additives US LLC Flocon 260 9343 03/03/2015
Merichem Company MC-510 9344 09/03/2015
Merichem Company MC-520 9345 27/04/2015
Merichem Company MC-530 9346 02/04/2015
Merichem Company MC-540 9347 09/03/2015
Merichem Company MC-550 9348 07/05/2015
BYK USA, Inc. Disperplast-1150 9350 23/04/2015
Nalco Canada ULC NALCO® EC1021W 9352 23/04/2015
Nalco Canada ULC ACRYL-EX® EC3085A 9353 08/04/2015
Buckeye International Inc. BUCKEYE BLUE 9354 09/03/2015
Evonik Corporation Protectosil® CHEM-TRETE® BSM 400 9355 03/03/2015
Evonik Corporation Protectosil® CIT 9356 08/04/2015
Calfrac Well Services Corp. DWP-926 9357 03/03/2015
3M Canada Company 3M™ Scotch-Weld™ Structural Plastic Adhesive DP8005, Part B 9358 14/04/2015
3M Canada Company 3M™ Scotch-Weld™ Structural Plastic Adhesive 8005, Black, Part B 9359 14/04/2015
CESI Chemical MA-844W CnF® Additive 9360 29/04/2015
3M Canada Company 3M™ Scotch-Weld™ Structural Plastic Adhesive DP8005, Black, Part B 9361 14/04/2015
Afton Chemical Corporation HiTEC® 5738 Performance Additive 9362 01/05/2015
Afton Chemical Corporation HiTEC® 5739 Performance Additive 9363 20/03/2015
Afton Chemical Corporation HiTEC® 1255 Performance Additive 9365 25/05/2015
Nalco Canada ULC SCORPION® EC1023A 9372 26/05/2015
Afton Chemical Corporation HiTEC® 5724 Performance Additive 9375 26/05/2015
Nalco Canada ULC SCORPION™ EC 1023H 9376 26/05/2015
BWA Water Additives US LLC Belclene 800 9408 26/05/2015
BWA Water Additives US LLC Belclene 810 9409 26/05/2015
Multi-Chem Production Chemicals Co. MC MX 3-4015 9413 26/05/2015
Nalco Canada ULC CLEAN N COR® EC1539A 9415 26/05/2015
Rohm and Haas Canada LP Preferred DC-15LT 9426 25/05/2015
Rohm and Haas Canada LP Preferred DC-15LT40 9427 25/05/2015

The subject of the claim for exemption on which the screening officer issued a decision for the following claims is different from the subject of the claim that was published in the Notice of Filing.

RN Notice of Filing Publication Date Original Subject of the Claim Revised Subject of the Claim
8885 2013-09-14 C.i. of two ingredients C.i. of four ingredients
9033 2014-01-25 C.i. of two ingredients C.i. and c. of two ingredients
9036 2014-01-25 C.i. and c. of two ingredients C.i. and c. of three ingredients
9044 2014-01-25 C.i. and c. of two ingredients C.i. of two ingredients and c. of five ingredients
9045 2014-01-25 C.i. of one ingredient C.i. and c. of one ingredient
9051 2014-01-25 C.i. and c. of five ingredients C.i. of five ingredients
9090 2014-01-25 C.i. of one ingredient C.i. and c. of one ingredient
9091 2014-01-25 C.i. of one ingredient C.i. and c. of one ingredient
9179 2014-04-26 C.i. of one ingredient C.i. and c. of seven ingredients
9268 2014-11-22 C.i. and c. of three ingredients C.i. of two ingredients and c. of four ingredients
9274 2014-11-22 C.i. of eight ingredients C.i. and c. of nine ingredients
9275 2014-11-22 C.i. of six ingredients, c. of three ingredients, and the product identifier of a controlled product C.i. of nine ingredients, c. of three ingredients, and the product identifier of a controlled product
9276 2014-11-22 C.i. of six ingredients, c. of three ingredients, and the product identifier of a controlled product C.i. of nine ingredients, c. of three ingredients, and the product identifier of a controlled product
9277 2014-11-22 C.i. of seven ingredients, c. of three ingredients, and the product identifier of a controlled product C.i. of nine ingredients, c. of three ingredients, and the product identifier of a controlled product
9278 2014-11-22 C.i. of six ingredients, c. of three ingredients, and the product identifier of a controlled product C.i. of eight ingredients, c. of three ingredients, and the product identifier of a controlled product
9288 2014-11-22 C.i. and c. of one ingredient C.i. and c. of two ingredients
9294 2015-01-31 C.i. and c. of one ingredient C.i. and c. of two ingredients
9298 2015-01-31 C.i. of one ingredient C.i. of two ingredients
9306 2015-01-31 C.i. of five ingredients C.i. and c. of seven ingredients
9307 2015-01-31 C.i. of five ingredients C.i. and c. of seven ingredients
9313 2015-01-31 C.i. of two ingredients C.i. and c. of two ingredients, and c. of one ingredient
9318 2015-01-31 C.i. of five ingredients C.i. of six ingredients
9325 2015-01-31 C.i. of one ingredient C.i. and c. of one ingredient
9334 2015-01-31 C.i. of one ingredient C.i. of four ingredients
9335 2015-01-31 C.i. of two ingredients C.i. and c. of two ingredients
9342 2015-01-31 C.i. of seven ingredients C.i. and c. of ten ingredients
9353 2015-01-31 C.i. of one ingredient C.i. and c. of one ingredient
9356 2015-01-31 C.i. and c. of one ingredient C.i. and c. of one ingredient, and c. of one ingredient
9358 2015-01-31 C.i. of two ingredients C.i. of one ingredient
9359 2015-01-31 C.i. of two ingredients C.i. of one ingredient
9361 2015-01-31 C.i. of two ingredients C.i. of one ingredient
9365 2015-04-25 C.i. of four ingredients C.i. and c. of seven ingredients, and c. of one ingredient
9408 2015-04-25 C.i. of two ingredients C.i. and c. of two ingredients
9409 2015-04-25 C.i. of two ingredients C.i. and c. of two ingredients
9413 2015-04-25 C.i. of two ingredients C.i. and c. of two ingredients

Note: C.i. = Chemical identity and c. = concentration.

Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that only the respective MSDSs in respect of the claims bearing RNs 9035, 9042, 9071, 9072, 9094, 9123, 9124, 9125, 9188, 9198, 9295, 9297, 9303, 9304, 9320, 9321, 9322, 9323, 9324, 9343, 9344, 9345, 9347, 9350, 9362, 9363, 9375, 9426 and 9427 complied with the requirements of the relevant legislation.

In all cases where the MSDS or the label was determined not to be in compliance with the relevant legislation, pursuant to subsection 16.1(1) of the Hazardous Materials Information Review Act, the claimant was given 30 days to provide the screening officer with a signed undertaking accompanied by the MSDS or the label amended as necessary.

CLAIMS FOR WHICH THE SCREENING OFFICER WAS SATISFIED THAT THE CLAIMANT HAD TAKEN THE MEASURES SET OUT IN THE UNDERTAKING

Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, the Chief Screening Officer hereby gives notice of information that has been disclosed on the relevant MSDS or label in compliance with an undertaking and the date on which the notice referred to in subsection 16.1(3) of the Act was issued.

RN: 8885

Date: 2015-07-15

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of two additional confidential ingredients, together with their percent concentrations, in an acceptable manner.
  2. Disclose an LD50 (rat, oral) value of 22.6 mL/kg for the ingredient “methacryloxypropyltimethoxysilane”.
  3. Disclose that an ingredient has been shown to cause fetotoxic effects in the presence of maternal toxicity in laboratory animals.

RN: 9002

Date: 2015-04-15

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient has been shown to cause skin corrosion in laboratory animals.
  2. Disclose that acute ingestion of and chronic dermal exposure to the confidential ingredient “sulfoxide” have been shown to cause central nervous system effects in laboratory animals.
  3. Add “oxides of sulphur” and “oxides of nitrogen” to the list of hazardous combustion products.
  4. Disclose an AIHA WEEL–TWA Exposure Limit for the confidential ingredient “sulfoxide” in an acceptable manner.
  5. Disclose ACGIH TLV–C Exposure Limits for the confidential ingredients “ether” and “alcohol” in an acceptable manner.
  6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E.

RN: 9032

Date: 2015-06-25

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (rabbit, dermal) value of 9.53 mL/kg for the ingredient “ethylene glycol”.
  2. Disclose an LD50 (rat, oral) value of 2 100 mg/kg for the confidential ingredient “branched alkylphenol”.
  3. Disclose an LD50 (rat, oral) value of 1 689 mg/kg for the confidential ingredient “long chain alkaryl sulfonate”.
  4. Disclose an LD50 (rat, oral) value of 4 g/kg for the ingredient “ethylene glycol”.
  5. Disclose that an ingredient has been shown to cause fetotoxic effects in the absence of maternal toxicity in laboratory animals.
  6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

RN: 9033

Date: 2015-04-17

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that ingredients have been shown to cause reproductive toxicity in laboratory animals.
  2. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

RN: 9034

Date: 2015-05-27

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.
  2. Disclose an ACGIH TLV–TWA value of 0.5 mg/m3 for the ingredient “(3-methylphenyl)((C-12-13 branched) phenyl) iodonium hexafluoroantimonate”.

RN: 9037

Date: 2015-05-19

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

RN: 9044

Date: 2015-06-22

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose ingestion as a route of exposure.
  2. Disclose that ingestion of an ingredient has been shown to cause central nervous system effects in humans.
  3. Disclose the presence of an additional confidential ingredient, together with its percent concentration, in an acceptable manner.

RN: 9045

Date: 2015-03-31

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

RN: 9046

Date: 2015-06-18

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that the confidential ingredient “carboxylic acid” has been shown to cause skin sensitization in laboratory animals.
  2. Disclose the generic chemical identity of the confidential ingredient “carboxylic acid”.
  3. Disclose an LD50 (rat, oral) value of 7 050 mg/kg for the ingredient “solvent naphtha, petroleum, heavy aromatic”.

RN: 9058

Date: 2015-06-23

The claimant had been advised to amend certain aspects of the content of the MSDS.

RNs: 9059 and 9062

Date: 2015-06-02

The claimant had been advised to amend the MSDS as indicated below.

  1. Add “oxides of carbon” and “oxides of nitrogen” to the list of hazardous decomposition products.

RN: 9061

Date: 2015-06-10

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Add “oxides of carbon” and “oxides of nitrogen” to the list of hazardous decomposition products.

RN: 9068

Date: 2015-05-06

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient has been shown to be an eye irritant.
  2. Disclose an LD50 (rabbit, dermal) value of 1.78 mL/kg for the confidential ingredient “ethoxylated alcohol”.

RN: 9069

Date: 2015-06-09

The claimant had been advised to amend certain aspects of the content of the MSDS.

RNs: 9090 and 9091

Date: 2015-06-24

The claimant had been advised to amend certain aspects of the content of the MSDS.

RN: 9100

Date: 2015-06-02

The claimant had been advised to amend certain aspects of the wording of the MSDS.

RN: 9179

Date: 2015-05-14

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity, percent concentration and CAS registry number for three hazardous ingredients.
  2. Disclose the presence of six additional confidential ingredients, together with their percent concentrations, in an acceptable manner.
  3. Disclose an ACGIH TLV–TWA value of 20 ppm for a hazardous ingredient.
  4. Disclose an AIHA WEEL–TWA value of 25 ppm for the confidential ingredient “n-butyraldehyde”.
  5. Disclose that ingredients in the controlled product have been shown to cause developmental toxicity in the presence of maternal toxicity in laboratory animals.

RN: 9232

Date: 2015-06-11

The claimant had been advised to amend certain aspects of the content of the MSDS.

RN: 9268

Date: 2015-06-02

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that ingestion of an ingredient has been shown to cause central nervous system effects.
  2. Disclose ingestion as a route of exposure.
  3. Disclose the percent concentration and CAS registry number for an additional hazardous ingredient.

RN: 9272

Date: 2015-05-06

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient has been shown to cause teratogenic effects in the absence of maternal toxicity.

RN: 9281

Date: 2015-04-09

The claimant had been advised to amend certain aspects of the wording of the MSDS.

RN: 9282

Date: 2015-05-08

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

RN: 9283

Date: 2015-05-28

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Add “oxides of carbon” to the list of hazardous decomposition products.
  2. Disclose that the controlled product is an eye and skin irritant.
  3. Disclose that an ingredient has been shown to cause mutagenic effects, in vitro.

RN: 9284

Date: 2015-05-28

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further had been advised to amend the MSDS as indicated below.

  1. Add “oxides of carbon” to the list of hazardous decomposition products.
  2. Disclose that an ingredient has been shown to cause mutagenic effects, in vitro.

RN: 9287

Date: 2015-06-02

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that ingestion of the confidential ingredient “pine terpene” has been shown to cause central nervous system effects.
  2. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.

RN: 9288

Date: 2015-06-02

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of an additional confidential ingredient, together with its percent concentration.
  2. Disclose an LD50 (rat, oral) value of 6.7 mL/kg for the confidential ingredient “nonionic surfactant”.

RN: 9291

Date: 2015-04-01

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Add “oxides of sulphur” and “oxides of nitrogen” to the list of hazardous combustion products.
  2. Disclose an LD50 (rat, oral) value of >500 mg/kg for the confidential ingredient “alkyl ester”.
  3. Disclose that an ingredient has been shown to be a skin irritant.

RN: 9292

Date: 2015-03-18

The claimant had been advised to amend certain aspects of the content of the MSDS.

RN: 9294

Date: 2015-04-09

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of an additional confidential ingredient, together with its percent concentration, in an acceptable manner.
  2. Disclose an ACGIH TLV–STEL value of 10 mg/m3 for the confidential ingredient “zirconium complex”.
  3. Add “oxides of sulphur” to the list of hazardous decomposition products.

RN: 9298

Date: 2015-04-07

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity and percent concentration for the confidential ingredient “anionic acrylic polymer”.
  2. Add “oxides of sulphur” and “oxides of nitrogen” to the list of hazardous decomposition products.
  3. Disclose an LD50 (rat, oral) value of 2 870 mg/kg for the ingredient “maleic acid”.
  4. Disclose that an ingredient has been shown to cause mutagenic effects, in vitro.

RN: 9300

Date: 2015-04-13

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

RN: 9301

Date: 2015-04-14

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Add “hydrochloric acid” to the list of hazardous decomposition products.

RN: 9302

Date: 2015-04-14

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

RN: 9305

Date: 2015-05-12

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an AIHA WEEL–TWA value of 7.45 mg/m3 for the ingredient “triethyl phosphate”.

RN: 9308

Date: 2015-03-09

The claimant had been advised to amend certain aspects of the content of the MSDS.

RN: 9310

Date: 2015-04-13

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (rat, oral) value of 2 000 mg/kg for the controlled product.
  2. Disclose an ACGIH TLV–C value of 2 mg/m3 for the confidential ingredient “neutralizing agent”.

RN: 9311

Date: 2015-03-05

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin and eye contact, disclose an approximate flush time of 30 minutes.
  2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have the casualty lie on their side, in the recovery position, in order to reduce the risk of aspiration.
  3. Disclose an LD50 (rat, oral) value of 1 689 mg/kg for the confidential ingredient “long chain alkenylamine”.

RN: 9312

Date: 2015-03-13

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (rat, oral) value of 625 mg/kg for the ingredient “methylenebiscyclohexanamine, 4,4’-”.
  2. Disclose an LD50 (rat, oral) value of 300 mg/kg for the confidential ingredient “mixed cycloaliphatic amines”.
  3. Disclose an LD50 (rabbit, dermal) value of 2 110 mg/kg for the confidential ingredient “mixed cycloaliphatic amines”.
  4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

RN: 9313

Date: 2015-05-29

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (rat, oral) value of 4 000 mg/kg for the ingredient “ethylene glycol”.
  2. Disclose an LD50 (rabbit, dermal) value of 9.53 mL/kg for the ingredient “ethylene glycol”.
  3. Disclose that ingestion of a hazardous ingredient has been shown to cause central nervous system effects and cardiopulmonary effects in humans.
  4. Disclose that ingestion of a hazardous ingredient has been shown to cause liver effects in laboratory animals.
  5. Disclose that an ingredient has been shown to cause teratogenic effects in the absence of maternal toxicity in laboratory animals.

RNs: 9314, 9315, 9316 and 9317

Date: 2015-04-14

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an acceptable concentration for the confidential ingredient “modified alkyl silane”.
  2. Add “hydrogen chloride” to the list of hazardous combustion products.
  3. Disclose an ACGIH TLV–STEL value of 400 ppm for the ingredient “isopropyl alcohol”.
  4. Disclose an LD50 (rabbit, dermal) value of 8.00 mL/kg for the ingredient “isopropyl alcohol”.
  5. Disclose that an ingredient has been shown to cause teratogenic effects in the presence of maternal toxicity in laboratory animals.

RN: 9319

Date: 2015-06-02

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose LD50 (rat, oral) values of >500 mg/kg and LD50 (rabbit, dermal) values of >1 000 mg/kg for the confidential ingredients “secondary alcohol”, “aromatic hydrocarbon 1”, and “oxo alcohol”.
  2. Disclose that chronic ingestion of an ingredient has been shown to cause hearing loss in laboratory animals.

RN: 9325

Date: 2015-05-12

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Add “hydrogen chloride” to the list of hazardous decomposition products.

RN: 9326

Date: 2015-03-31

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

RN: 9327

Date: 2015-05-08

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that the confidential ingredient “oxidizing agent” has been shown to be corrosive to the eyes.
  2. Disclose an ACGIH TLV–STEL value of 1 ppm for the confidential ingredient “oxidizing agent”.
  3. Disclose that an ingredient has been shown to cause mutagenic effects, in vitro.

RN: 9328

Date: 2015-05-14

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (rat, oral) value of 847 mg/kg for the confidential ingredient “inorganic sodium compound”.
  2. Disclose an LD50 (rat, oral) value of 1 870 mg/kg for the confidential ingredient “potash”.
  3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class B3.

RN: 9330

Date: 2015-06-03

The claimant had been advised to amend certain aspects of the content of the MSDS.

RN: 9331

Date: 2015-06-03

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (rat, oral) value of 3 000 mg/kg for the controlled product.

RN: 9332

Date: 2015-03-13

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

RN: 9333

Date: 2015-06-02

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (rat, oral) value of 2.83 mL/kg for the confidential ingredient “glycol ether DB”.
  2. Disclose an LD50 (rat, dermal) value of 3.56 mL/kg for the confidential ingredient “glycol ether DB”.

RN: 9334

Date: 2015-04-07

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the presence of three additional confidential ingredients, together with their chemical identities and percent concentrations, in an acceptable manner.

RN: 9336

Date: 2015-07-14

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D1A, D2B and B3.
  2. Disclose ingestion as a route of exposure.
  3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  4. Disclose an LD50 (rabbit, dermal) value of 168 mg/kg for the confidential ingredient “thio alcohol”.
  5. Disclose that an ingredient has been shown to cause skin sensitization in laboratory animals.

RN: 9337

Date: 2015-04-07

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the presence of an additional ingredient, together with its chemical identity and percent concentration.
  2. Disclose an LD50 (rat, oral) value of 1.0 g/kg for the ingredient “masodol 91-8 linear primary alcohol ethoxylate surfactant”.
  3. Disclose an LC50 (rat, aerosol, 4 hours) value of >2.5 g/m3 for the confidential ingredient “organic carboxylic compound”.
  4. Disclose that an ingredient has been shown to cause teratogenic effects in the presence of maternal toxicity in laboratory animals.

RN: 9338

Date: 2015-04-10

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an ACGIH TLV–STEL value and an ACGIH TLV–TWA value for the confidential ingredient “aliphatic alcohol”.

RNs: 9339 and 9340

Date: 2015-03-13

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that acute inhalation and acute ingestion of the ingredient “2-propanol” have been shown to cause central nervous system effects.
  2. Disclose a statement to the effect that metal containers should be grounded during the transfer of large quantities of the controlled product.
  3. Disclose an ACGIH TLV–TWA value of 10 ppm for the confidential ingredient “organic acid”.
  4. Disclose an ACGIH TLV–STEL value of 15 ppm for the confidential ingredient “organic acid”.
  5. Add “oxides of sulphur” to the list of hazardous decomposition products.
  6. Disclose an LD50 (rat, oral) value of >500 mg/kg for the confidential ingredient “organic acid”.
  7. Disclose that an ingredient has been shown to cause teratogenic and embryotoxic effects in the presence of maternal toxicity in laboratory animals.

RN: 9346

Date: 2015-06-01

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose an acceptable concentration for the confidential ingredient “hypodicarbonous acid”.
  2. Disclose an LD50 (rat, oral) value of 960 mg/kg and an LD50 (rabbit, dermal) value of 2.8 mL/kg for the confidential ingredient “ethoxylated nonylphenol”.

RN: 9348

Date: 2015-05-29

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an LC50 (aerosol, rat, 4 hours) value of 1.72 mg/L for the ingredient “petroleum hydrocarbon”.
  2. Disclose that an ingredient has been shown to cause mutagenic effects, in vitro.
  3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D1B and D2B.
  4. Disclose the additional WHMIS D1 pictogram, if WHMIS pictograms are shown on the MSDS.

RN: 9352

Date: 2015-05-26

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that ingestion of the ingredient “isopropanol” has been shown to cause central nervous system effects in humans.
  2. Disclose ingestion as an additional route of exposure.
  3. Disclose an LD50 (rat, oral) value of >1 000 mg/kg for the confidential ingredient “imidazoline derivative”.
  4. Disclose an LD50 (rabbit, dermal) value of >2 000 mg/kg for the confidential ingredient “imidazoline derivative”.
  5. Disclose an LD50 (rabbit, dermal) value of 6 280 mg/kg for the ingredient “isopropanol”.

RN: 9353

Date: 2015-05-12

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient has been shown to be corrosive to the eyes.

RN: 9354

Date: 2015-03-13

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient has been shown to cause skin sensitization in laboratory animals.

RN: 9355

Date: 2015-03-06

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

RN: 9356

Date: 2015-04-15

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 value for the controlled product in an acceptable manner.

RN: 9357

Date: 2015-03-12

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

RNs: 9358, 9359 and 9361

Date: 2015-04-20

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (rat, oral) value of 16 465 mg/kg for the ingredient “2-ethylhexyl methacrylate”.

RN: 9360

Date: 2015-05-08

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose a statement to the effect that metal containers should be grounded during the transfer of large quantities of the controlled product.
  2. Disclose an LD50 (rabbit, dermal) value of 6 280 mg/kg for the ingredient “isopropyl alcohol”.
  3. Disclose that ingestion of the ingredient “triethylene glycol” has been shown to cause teratogenic effects in the absence of maternal toxicity.
  4. Disclose that ingestion and inhalation of the ingredient “isopropyl alcohol” have been shown to cause teratogenic effects in the presence of maternal toxicity.
  5. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

RN: 9372

Date: 2015-06-25

The claimant had been advised to amend certain aspects of the content of the MSDS.

RN: 9376

Date: 2015-06-25

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient has been shown to be corrosive to the eyes.
  2. Disclose that an ingredient has been shown to be corrosive to the skin.
  3. Disclose an LD50 (rat, oral) value of 7 050 mg/kg for the confidential ingredient “heavy aromatic naptha”.

RNs: 9408 and 9409

Date: 2015-05-28

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient has been shown to be corrosive to the eyes.
  2. Disclose an LD50 (rat, oral) value of 2 870 mg/kg for the confidential ingredient “organic acid”.

RN: 9413

Date: 2015-07-20

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the ACGIH skin notation for the ingredient “methyl alcohol”.

RN: 9415

Date: 2015-07-17

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose that ingestion of a hazardous ingredient has been shown to cause central nervous system effects and cardiovascular effects in humans.
  2. Disclose a statement to the effect that metal containers should be grounded during the transfer of large quantities of the controlled product.
  3. Disclose an LD50 (rabbit, dermal) value of 168 mg/kg for the confidential ingredient “organic sulfur compound”.

CLAIMS FOR WHICH THE SCREENING OFFICER ORDERED THE CLAIMANT TO COMPLY WITH THE APPLICABLE DISCLOSURE REQUIREMENTS

In the case of the following claims, either the claimant did not supply the screening officer with a signed undertaking or the screening officer was not satisfied that the claimant had taken the measures set out in the undertaking in the manner and within the period specified in it. Pursuant to subsection 17(1) of the Hazardous Materials Information Review Act, the screening officer ordered the claimant to comply with the requirements of the relevant legislation within 30 days from the expiry of the appeal period, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the screening officer within 30 days of expiry of the appeal period.

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer hereby gives notice of information that the screening officer ordered to be disclosed on the MSDS reviewed by the screening officer and the date of the order.

RN: 9053

Date: 2015-07-10

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the percent concentrations of two additional confidential ingredients in an acceptable manner.
  2. Disclose an LD50 (rat, oral) value of 6.72 g/kg for the ingredient “2-propanol, 1,1′-iminobis-”.

RN: 9290

Date: 2015-04-08

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose ingestion as a route of exposure.
  2. Disclose that an ingredient has been shown to be a skin irritant.

RN: 9296

Date: 2015-04-08

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose ingestion and eye contact as routes of exposure.
  2. Disclose the presence of an additional confidential ingredient, together with its percent concentration, in an acceptable manner.
  3. Add “oxides of sulphur” and “oxides of nitrogen” to the list of hazardous decomposition products.

CLAIMS FOR WHICH THE SCREENING OFFICER ISSUED THE DECISION THAT THE CLAIM FOR EXEMPTION WAS EITHER PARTIALLY VALID OR INVALID

In the case of the following claims, the screening officer issued the decision that the claim for exemption was partially valid.

Pursuant to section 18 of the Hazardous Materials Information Review Act, the Chief Screening Officer hereby gives notice of information that the screening officer ordered to be disclosed on an MSDS or a label pursuant to subsection 16(1) and information that has been disclosed on the relevant MSDS or label in compliance with an undertaking, and the dates on which the orders and notices referred to in subsection 16.1(3) of the Act were issued.

RN: 9016

Date of compliance undertaking: 2015-04-15

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an OSHA PEL–TWA Exposure Limit for the confidential ingredient “alcohol”.
  2. Disclose that an ingredient has been shown to cause skin corrosion in laboratory animals.
  3. Disclose that acute ingestion and acute dermal exposure of an ingredient has been shown to cause central nervous system effects in laboratory animals.
  4. Add “oxides of sulphur” to the list of hazardous combustion products.
  5. Disclose an LD50 (rat, oral) value of 14 500 mg/kg for the confidential ingredient “sulfoxide”.
  6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E.

RN: 9036

Date of compliance undertaking: 2015-04-23

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

RN: 9051

Date of order: 2015-04-07

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration for the confidential ingredient “alkoxylated amine”.
  2. Disclose an LD50 (rat, oral) value of 0.41 g/kg for the confidential ingredient “alkoxylated fatty polyamines”.
  3. Disclose an LD50 (rat, oral) value of 783 mg/kg for the confidential ingredient “fatty polyamines”.
  4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

RN: 9141

Date of order: 2015-05-22

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity and CAS registry number of the ingredient for which the claim was made but was found to be invalid.
  2. Disclose eye contact as a route of entry.

RN: 9274

Date of compliance undertaking: 2015-04-29

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of an additional confidential ingredient, together with its percent concentration, in an acceptable manner.
  2. Disclose that an ingredient has been shown to cause skin sensitization in laboratory animals.

RNs: 9275 and 9277

Date of order: 2015-05-22

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration range for the hazardous ingredient “ethylene glycol” in an acceptable manner.
  2. Disclose an LD50 (rat, oral) value of 4.92 mL/kg for the confidential ingredient “cyclic amine (1)”.
  3. Disclose an LD50 (rabbit, dermal) value of 16.0 mL/kg for the confidential ingredient “cyclic amine (1)”.

RNs: 9276 and 9278

Date of order: 2015-05-22

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (rat, oral) value of 4.92 mL/kg for the confidential ingredient “cycloammonium sulphate (1)”.
  2. Disclose an LD50 (rat, oral) value of 3.73 mL/kg for the confidential ingredient “cycloammonium sulphate (2)”.
  3. Disclose an LD50 (rabbit, dermal) value of 16.0 mL/kg for the confidential ingredient “cycloammonium sulphate (1)”.

RN: 9299

Date of compliance undertaking: 2015-03-09

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that the confidential ingredient “fatty acid” has been shown to cause skin sensitization in laboratory animals.

RNs: 9306 and 9307

Date of order: 2015-05-22

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of two additional confidential ingredients, together with their percent concentrations, in an acceptable manner.
  2. Disclose an LD50 (rat, dermal) value of 2.38 mL/kg for the ingredient “2-ethyl hexanol”.

RN: 9318

Date of order: 2015-03-10

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity, percent concentration and CAS registry number for an additional hazardous ingredient.

Date of order: 2015-04-13

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of the additional confidential ingredient, together with its percent concentration, in an acceptable manner.
  2. Disclose an LD50 (rat, oral) value of 8 697 mg/kg for the confidential ingredient “alkyl phenol”.
  3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class B3.

RN: 9335

Date of compliance undertaking: 2015-05-27

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (rat, oral) value of 4.7 g/kg for the ingredient “hexylene glycol”.
  2. Disclose an LD50 (rabbit, dermal) value of 13.30 mL/kg for the ingredient “hexylene glycol”.
  3. Disclose that acute ingestion of an ingredient has been shown to cause central nervous system effects in laboratory animals.
  4. Disclose that an ingredient has been shown to cause teratogenic effects in the presence of maternal toxicity in laboratory animals.

RN: 9342

Date of compliance undertaking: 2015-06-23

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that ingredients have been shown to be corrosive to the eyes and skin.
  2. Disclose the presence of three additional confidential ingredients, together with their percent concentrations, in an acceptable manner.
  3. Disclose an LD50 (rat, oral) value of 1 400 mg/kg for the confidential ingredient “alkyl phosphate (II)”.
  4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D1B and E.

RN: 9365

Date of compliance undertaking: 2015-06-26

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of three additional confidential ingredients, together with their percent concentrations, in an acceptable manner.
  2. Disclose that an ingredient has been shown to cause skin sensitization in laboratory animals.
  3. Disclose that an ingredient has been shown to be an eye irritant.

CLAIMS FOR WHICH THE SCREENING OFFICER ISSUED A DECISION ON THE CLAIM FOR EXEMPTION BUT WHICH WERE DISCONTINUED PRIOR TO THE ISSUANCE OF EITHER A SIGNED UNDERTAKING OR SIGNED ORDERS

The screening officer has identified the following instances of non-compliance with the requirements of the relevant legislation.

RN: 8557

Date of statement of decision: 2015-06-13

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Add “oxides of sulphur” to the list of hazardous decomposition products.
  2. Disclose the exposure limit of an ingredient and that it has been classified as a suspected human carcinogen (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH).
  3. Disclose that an ingredient has been shown to be corrosive to the skin and eyes.
  4. Disclose that an ingredient has been shown to cause teratogenic and embryotoxic effects in the presence of maternal toxicity.
  5. Disclose an LC50 (rat, vapour, 4 hours) value of 450 ppm for a confidential ingredient.
  6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.

RN: 9403

Date of statement of decision: 2015-05-27

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of the additional confidential ingredients, together with their percent concentrations, in an acceptable manner.
  2. Disclose the chemical identity and percent concentration for an additional hazardous ingredient.
  3. Disclose the percent concentration for a confidential ingredient.
  4. Disclose an LD50 (rat, oral) value of 2 551 mg/kg for a confidential ingredient.

[43-1-o]

DEPARTMENT OF INDUSTRY

OFFICE OF THE REGISTRAR GENERAL

Appointments

Name and position Order in Council
Cheverie, The Hon. Wayne D. 2015-1217

Government of Prince Edward Island

 

Administrator

 

October 17 to October 19, 2015

 
Government of Saskatchewan  

Administrators

 

Jackson, The Hon. Georgina R.

2015-1218

October 19 to October 23, 2015

 

Lane, The Hon. J. Gary

2015-1219

December 14 to December 31, 2015

 
Watson, The Hon. Jack 2015-1216

Government of Alberta

 

Administrator

 

October 17 to October 31, 2015

 

October 16, 2015

DIANE BÉLANGER
Official Documents Registrar

[43-1-o]